HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
RecruitingNCT07120477

Esketamine or crisis planning for suicide prevention

About this titleRead the official source — NCT07120477
Medication studyAges 14+Brazil
The study in practice

Understand this study

Who could participate?

Listed age limits: from 14 years.

What will I do during this study?

You are randomly assigned to one of three groups alongside enhanced usual care: one group receives a single monitored intravenous esketamine infusion, one receives a 20–45 minute crisis response planning session with a trained clinician, and one receives enhanced usual care alone. The record describes early outpatient consultation and safety counselling as part of that care.

Listed locations
IndaiatubaSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Participation duration
The registry describes either one infusion or one 20–45 minute clinician session, depending on group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 1, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
478
Sponsor
University of Sao Paulo
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Brazil
Age range
Over 14 Years
Official registry ID
NCT07120477
Official title
Show the full official title

Esketamine Versus Crisis Response Planning Versus Enhanced Treatment as Usual for Suicide Prevention: A Pragmatic Randomized Trial in a Brazilian Municipality (SAVE)

Recruitment & locations

Currently recruiting

Indaiatuba

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Sao Paulo, a university.

Does this study involve medication?

Yes. The study involves medication, including Intravenous Esketamine.

Who can participate?

Listed age limits: from 14 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies